AddLife (ALIF B.ST) Stock Price
AddLife Price
Revenue has compounded at 20.9% per year over the past 10 years to 10.44 B SEK. Earnings per share have grown at 17.8% per year over the last 10 years. AddLife's net margin stands at 5.4%, down from 9.0% several years earlier. AddLife currently offers a dividend yield of about 0.45%. The payout ratio is around 16% of earnings. Analysts set a median price target of 218.28 SEK, implying 31.7% above the current price. Of 8 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 23% above its 52-week low.
AddLife stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of AddLife over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how AddLife stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing AddLife's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | AddLife Price |
|---|---|
| 8/31/2026 | 165.80 SEK |
| 8/28/2026 | 166.40 SEK |
| 8/27/2026 | 166.10 SEK |
| 8/26/2026 | 162.50 SEK |
| 8/25/2026 | 162.30 SEK |
| 8/24/2026 | 161.80 SEK |
| 8/21/2026 | 162.70 SEK |
| 8/20/2026 | 160.50 SEK |
| 8/19/2026 | 155.10 SEK |
| 8/18/2026 | 156.70 SEK |
| 8/17/2026 | 157.60 SEK |
| 8/14/2026 | 160.90 SEK |
| 8/13/2026 | 157.60 SEK |
| 8/12/2026 | 158.40 SEK |
| 8/11/2026 | 158.90 SEK |
| 8/10/2026 | 160.00 SEK |
| 8/7/2026 | 164.70 SEK |
| 8/6/2026 | 162.00 SEK |
| 8/5/2026 | 163.10 SEK |
| 8/4/2026 | 164.20 SEK |
| 7/31/2026 | 161.60 SEK |
| 7/30/2026 | 163.90 SEK |
| 7/29/2026 | 160.90 SEK |
| 7/28/2026 | 158.40 SEK |
| 7/27/2026 | 157.60 SEK |
| 7/24/2026 | 157.50 SEK |
| 7/23/2026 | 154.80 SEK |
| 7/22/2026 | 155.70 SEK |
| 7/21/2026 | 157.00 SEK |
| 7/20/2026 | 157.00 SEK |
AddLife Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
AddLife Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB SEK |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB SEK |
| EBITB SEK |
| EBIT MARGIN% |
| NET INCOMEM SEK |
| NET INCOME GROWTH% |
| DIVIDENDDIV.SEK |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.56 | 1.49 | 2.33 | 2.48 | 3.48 | 5.27 | 7.99 | 9.08 | 9.69 | 10.29 | 10.44 | 10.93 | 11.58 | 12.24 |
| – | -4.93 | 57.10 | 6.34 | 40.23 | 51.57 | 51.56 | 13.66 | 6.62 | 6.21 | 1.52 | 4.64 | 6.02 | 5.64 |
| 35.02 | 34.48 | 36.18 | 36.07 | 34.72 | 35.07 | 36.36 | 38.08 | 37.96 | 38.25 | 38.09 | 38.09 | 38.09 | 38.09 |
| 0.55 | 0.51 | 0.84 | 0.90 | 1.21 | 1.85 | 2.91 | 3.46 | 3.68 | 3.93 | 3.98 | 4.16 | 4.41 | 4.66 |
| 0.10 | 0.12 | 0.18 | 0.17 | 0.20 | 0.70 | 1.03 | 0.84 | 0.81 | 0.80 | 0.99 | 1.01 | 1.12 | 1.12 |
| 6.47 | 8.15 | 7.54 | 6.93 | 5.81 | 13.33 | 12.88 | 9.23 | 8.31 | 7.79 | 9.51 | 9.24 | 9.64 | 9.19 |
| 77.00 | 93.00 | 120.00 | 129.00 | 140.00 | 517.00 | 718.00 | 480.00 | 190.00 | 252.00 | 560.00 | 666.00 | 709.00 | 945.00 |
| – | 20.78 | 29.03 | 7.50 | 8.53 | 269.29 | 38.88 | -33.15 | -60.42 | 32.63 | 122.22 | 18.93 | 6.46 | 33.29 |
| – | – | 1.50 | 2.20 | 2.20 | 0.50 | 1.50 | 2.00 | 1.20 | 0.50 | 0.75 | 1.50 | 1.50 | 1.50 |
| – | – | – | 46.67 | – | -77.27 | 200.00 | 33.33 | -40.00 | -58.33 | 50.00 | 100.00 | – | – |
| 86.82 | 100.97 | 102.21 | 101.35 | 111.08 | 112.13 | 119.97 | 122.25 | 121.86 | 121.86 | 121.86 | 121.86 | 121.86 | 121.86 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales AddLife generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue AddLife retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare AddLife's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares AddLife has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against AddLife's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
AddLife stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
AddLife Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
AddLife business model & stock analysis
AddLife SWOT Analysis
Strengths
- Established presence in the healthcare industry
- Strong brand reputation
- Diverse portfolio of healthcare products
- Robust distribution network
Weaknesses
- High dependency on a few key products
- Limited international presence
- Relatively small customer base
Opportunities
- Growing demand for healthcare products
- Expansion into new geographic markets
- Increasing adoption of e-commerce in the healthcare sector
Threats
- Intense competition from established players
- Regulatory changes impacting the healthcare industry
- Economic downturn affecting consumer spending on healthcare
AddLife Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
AddLife historical P/E ratio, EBIT multiple, and P/S ratio
AddLife annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
AddLife shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
AddLife stock splits
AddLife Dividend History
10 years of dividend payments
AddLife dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
AddLife dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current AddLife forecasts and price targets in September 2026
Analyst Price Targets 2026AddLife Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 7/13/2023 | 0.70SEK | - | 2.18 BSEK | - | 2023 Q2 |
| 4/26/2023 | 0.74SEK | - | 2.37 BSEK | - | 2023 Q1 |
| 2/2/2023 | 0.48SEK | - | 2.18 BSEK | - | 2022 Q4 |
| 10/27/2022 | 0.47SEK | - | 1.95 BSEK | - | 2022 Q3 |
| 7/15/2022 | 0.91SEK | - | 2.12 BSEK | - | 2022 Q2 |
| 4/28/2022 | 1.47SEK | - | 2.19 BSEK | - | 2022 Q1 |
| 2/4/2022 | 1.80SEK | - | 2.53 BSEK | - | 2021 Q4 |
| 2/13/2018 | 0.58SEK | - | 758.51 MSEK | - | 2017 Q4 |
| 10/26/2017 | 0.26SEK | - | 540.49 MSEK | - | 2017 Q3 |
EESG©
Eulerpool ESG Scorecard© for the AddLife stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
AddLife shareholder structure
| % | Name |
|---|---|
6.48264% | |
2.72173% | |
1.78768% | |
1.23569% | |
1.20230% | |
1.12636% |
AddLife Executives and Management Board
8 members · avg. age 62 · 50 % women
Mr. Fredrik Dalborg (53)
President, Chief Executive Officer
10.30 M SEK
Management
Ms. Christina Rubenhag (55)
Chief Financial Officer
Board of Directors
Mr. Johan Sjoe (58)
Independent Chairman of the Board
Ms. Eva Nilsagard (61)
Independent Director
Ms. Eva Elmstedt (65)
Independent Director
Mr. Stefan Hedelius (56)
Independent Director
Ms. Birgit Norinder (77)
Independent Director
Mr. Hakan Roos (70)
Independent Director
Frequently asked questions about AddLife
The business model of AddLife AB revolves around the distribution and marketing of high-quality products and services within the life science sector. AddLife AB primarily focuses on three business areas: Labtech, Medtech, and Diagnostics. Labtech involves offering innovative solutions, including equipment and consumables, to laboratories and research institutions. Medtech includes the distribution of medical technology products for healthcare and rehabilitation. Diagnostics encompasses the supply of diagnostic products and services for medical laboratories. AddLife AB aims to provide its customers with comprehensive solutions, strong expertise, and reliable deliveries to meet their needs in the life science industry.
AddLife AB is primarily active in the industries of life sciences and healthcare.
The main competitors of AddLife AB in the market are its industry peers, such as Getinge AB, Lifco AB, and Elekta AB.
AddLife AB is a Swedish company specializing in the distribution and sales of high-quality products for the healthcare sector. Founded in 2016, AddLife has quickly become a leading player in the Nordic region, providing services and solutions within the fields of laboratory equipment, diagnostics, and biotechnology. The company focuses on areas such as research, healthcare, and life science, offering a wide range of products from renowned global manufacturers. With its extensive expertise and strong market presence, AddLife continues to evolve and expand its operations, driving advancements in healthcare and contributing to the well-being of individuals and society as a whole.
AddLife AB, a leading company in the life science sector, has achieved several notable milestones. The company has successfully expanded its presence and market share, becoming a key player in the industry. AddLife AB has made strategic acquisitions, enhancing its product portfolio and geographical reach. Additionally, it has formed collaborations with renowned partners, reinforcing its position as an innovative and reliable partner in the life science field. The company's steadfast commitment to customer satisfaction and focus on delivering high-quality products and services have contributed to its continued success and growth. AddLife AB's dedication to excellence has led to significant achievements and recognition within the life science industry.
AddLife AB is primarily present in Sweden and Finland.
AddLife AB is a leading company that represents strong values and a robust corporate philosophy. They prioritize customer satisfaction and strive to deliver exceptional products and services. AddLife AB values integrity, professionalism, and continuous improvement in everything they do. With a focus on innovation and sustainability, the company aims to create long-term value for both stakeholders and society as a whole. By providing high-quality healthcare solutions and fostering partnerships, AddLife AB demonstrates their commitment to improving people's lives.
Analysts currently set an average price target of 208.59 SEK for the AddLife stock (median: 218.28 SEK), implying +25.8 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the AddLife stock: 5 recommend buying, 3 holding and 0 selling. For 2026, analysts expect AddLife to generate revenue of 10.93 B SEK and earnings per share of 5.47 SEK.
Converted at the current exchange rate, the AddLife share trades at 14.90 EUR (165.80 SEK).
The AddLife share (ALIF B.ST) is listed on 6 stock exchanges, including: Frankfurt (1AD1.F), München (1AD1.MU), London (0REZ.L), London (0REZ.L).
The Swedish company AddLife AB is a B2B company that offers products and solutions for the healthcare sector. The company focuses on four main business areas: Life Science, Labtech, Medtech, and Healthcare. AddLife offers its customers a wide range of products, services, and solutions in these areas. In the Life Science area, AddLife offers products and solutions for the research and development of pharmaceutical and biotechnology companies. This includes, for example, analysis instruments, laboratory equipment and chemicals, as well as consumables. The Labtech area specializes in laboratory equipment. This includes, for example, workstations, technical systems, and consumables. Software solutions for the execution and evaluation of experiments are also part of the offer. In the Medtech area, AddLife offers products and solutions for diagnostics and therapy. This includes, for example, instruments for cardiology or laboratory medicine, as well as consumables for medical examinations. Special products for infection control are also offered. In the Healthcare area, AddLife offers products and solutions for nursing and rehabilitation. This includes, for example, aids for mobility promotion, products for wound care or incontinence care. AddLife does not sell its products and solutions directly to end customers, but to companies and institutions in the healthcare sector such as hospitals, practices, or research institutes. AddLife follows a clear strategy to expand and develop its business. This includes, for example, acquisitions, cooperations, and networking. This way, AddLife can expand its product portfolio and use the expertise of its partners. The internationalization of the business also plays an important role. AddLife is already active in several countries worldwide and plans to further expand its business. The business model of AddLife is based on long-term customer relationships and a high quality of products and services. AddLife works closely with its customers and offers them customized solutions. Customers can benefit from the extensive experience and expertise of AddLife. In summary, AddLife is an innovative and future-oriented company that offers products and solutions for the healthcare sector. Through its clear strategy, high quality products and services, and collaboration with partners and customers, AddLife aims to further expand its business and strengthen its position in the market.
The expected revenue of AddLife is 10.93 B SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of AddLife is 666.18 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of AddLife is currently 30.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the AddLife stock.
The price-to-sales ratio (P/S) of AddLife is currently 1.85. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the AddLife stock.
The Eulerpool Quality Score for AddLife is 7/10.
The ISIN of AddLife is SE0014401378. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of AddLife is A2P4TH. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of AddLife is ALIF B.ST. The ticker symbol is used to trade AddLife shares on the stock exchange.
Over the past 12 months, AddLife paid a dividend of 0.75 SEK . This corresponds to a dividend yield of about 0.45 %. For the coming 12 months, AddLife is expected to pay a dividend of 1.50 SEK.
The current dividend yield of AddLife is 0.45 %.
AddLife pays a dividend, distributed in the months of , , , .
AddLife paid dividends every year for the past 9 years.
For the upcoming 12 months, dividends amounting to 1.50 SEK are expected. This corresponds to a dividend yield of 0.90 %.
AddLife is assigned to the 'Health' sector.
To receive the latest dividend of AddLife from amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, AddLife distributed 0.5 SEK as dividends.
The dividends of AddLife are distributed in SEK.
AddLife stock
AddLife Peer Group
AddLife Ticker
AddLife FIGI
All fundamentals and in-depth analysis of AddLife
Our stock analysis for AddLife stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AddLife. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.